Search Home >>

Response to “What constitutes scientific justification for inclusion of recovery assessment in pre-clinical studies supporting first time in man (FTIM)?” Sally Robinson and Ruth Roberts, Drug Safety and Metabolism, AstraZeneca, Alderley Park, Macclesfield, UK

DOI: 10.1016/j.yrtph.2014.09.006
Title: Response to “What constitutes scientific justification for inclusion of recovery assessment in pre-clinical studies supporting first time in man (FTIM)?” Sally Robinson and Ruth Roberts, Drug Safety and Metabolism, AstraZeneca, Alderley Park, Macclesfield, UK
Journal Title: Regulatory Toxicology and Pharmacology
Volume: 70
Issue: 2
Publication Date: November 2014
Start Page: 574
End Page: 574
Published online: online 16 September 2014
ISSN: 0273-2300
Author: David R. Jones (Expert Pharmaco-Toxicologist)
Affiliations:
  • MHRA, United Kingdom
  • Corresponding information:

    Related Paper

    Top 10 Paper

    New 10 Paper

    PC Version